Literature DB >> 29076907

Benign Traumatic Rib Fracture: A Potential Pitfall on 68Ga-Prostate-Specific Membrane Antigen PET/CT for Prostate Cancer.

Mads Ryø Jochumsen1, André H Dias, Kirsten Bouchelouche.   

Abstract

Two, respectively, 72- and 76-year-old men with recently diagnosed high-risk prostate cancer were referred for primary staging with Ga-prostate-specific membrane antigen (PSMA) PET/CT. In both patients, the PET scans revealed increased Ga-PSMA uptake in, respectively, 3 and 4 rib fractures, characteristically placed as "pearls on a string." These cases illustrate important pitfalls when reporting PSMA PET.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29076907     DOI： 10.1097/RLU.0000000000001871

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  7 in total

1.  [68Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate Cancer.

Authors:  Nader Hirmas; Akram Al-Ibraheem; Ken Herrmann; Abedalatif Alsharif; Haider Muhsin; Jamal Khader; Ali Al-Daghmin; Samer Salah
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

Review 2.  Update of PSMA Theranostics in Prostate Cancer: Current Applications and Future Trends.

Authors:  Chalermrat Kaewput; Sobhan Vinjamuri
Journal:  J Clin Med       Date:  2022-05-12       Impact factor: 4.964

3.  Matched-Pair Comparison of 68Ga-PSMA-11 PET/CT and 18F-PSMA-1007 PET/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical Prostatectomy.

Authors:  Isabel Rauscher; Markus Krönke; Michael König; Andrei Gafita; Tobias Maurer; Thomas Horn; Kilian Schiller; Wolfgang Weber; Matthias Eiber
Journal:  J Nucl Med       Date:  2019-06-28       Impact factor: 11.082

Review 4.  Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.

Authors:  Henk B Luiting; Pim J van Leeuwen; Martijn B Busstra; Tessa Brabander; Henk G van der Poel; Maarten L Donswijk; André N Vis; Louise Emmett; Phillip D Stricker; Monique J Roobol
Journal:  BJU Int       Date:  2019-11-29       Impact factor: 5.588

5.  Added value of 68Ga-PSMA PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer and a previous 99mTc bone scintigraphy.

Authors:  Helle D Zacho; Søren Ravn; Ali Afshar-Oromieh; Joan Fledelius; June A Ejlersen; Lars J Petersen
Journal:  EJNMMI Res       Date:  2020-04-08       Impact factor: 3.138

Review 6.  Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings.

Authors:  Felipe de Galiza Barbosa; Marcelo Araujo Queiroz; Rafael Fernandes Nunes; Larissa Bastos Costa; Elaine Caroline Zaniboni; José Flavio Gomes Marin; Giovanni Guido Cerri; Carlos Alberto Buchpiguel
Journal:  Cancer Imaging       Date:  2020-03-14       Impact factor: 3.909

7.  Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer.

Authors:  Xing Zhou; YingChun Li; Xiao Jiang; XiaoXiong Wang; ShiRong Chen; TaiPeng Shen; JinHui You; Hao Lu; Hong Liao; Zeng Li; ZhuZhong Cheng
Journal:  Front Oncol       Date:  2021-02-01       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.